In August 2025, a subject in the high-dose group of Huida Gene's HG302 Duchenne muscular dystrophy gene editing clinical trial died from a severe immune reaction triggered by AAV, and the incident was not disclosed until about a year later.
Location: China ·
Importance IV ·
Verification: Reported ·
View causal chain →